Esophageal Cancer Overview
18 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the average resting lumen size of the esophagus?

  • 2cm x 5cm
  • 5cm x 6cm
  • 2cm x 3cm (correct)
  • 1cm x 1cm
  • Which of the following is TRUE about epidemiology of esophageal cancer?

  • Squamous cell carcinoma is the most common type in the USA, and worldwide.
  • Adenocarcinoma is the most common type in the USA, and worldwide.
  • Squamous cell carcinoma is the most common type in the USA, and adenocarcinoma is the most common type worldwide.
  • Adenocarcinoma is the most common type in the USA, and squamous cell carcinoma is the most common type worldwide. (correct)
  • What age group is most commonly affected by esophageal cancer?

  • 40-50 years old
  • 50-60 years old
  • 60-70 years old (correct)
  • >70 years old
  • You are evaluating a patient who recently underwent an Upper endoscopy and was diagnosed with a biopsy-proven esophageal adenocarcinoma arising in the region of the gastroesophageal junction. The endoscopy report notes that the epicenter of the tumor was 2.5 cm caudal to the gastroesophageal junction. Which of the following is the most appropriate classification and management approach for this tumor?

    <p>Classify as Siewart type III, and treat as gastric cancer (D)</p> Signup and view all the answers

    What is the overall 5-year survival rate for esophageal cancer?

    <p>~18-20% (D)</p> Signup and view all the answers

    Which of the following is TRUE about the anatomy of the esophagus?

    <p>The esophagus does not have a serosa. (C)</p> Signup and view all the answers

    Which of the following risk factors is associated with the highest increase in risk for esophageal adenocarcinoma?

    <p>Barrett’s esophagus (D)</p> Signup and view all the answers

    What is the most common genetic mutation found in esophageal cancer biopsies?

    <p>TP53 (C)</p> Signup and view all the answers

    Which of the following is TRUE about HER2 status in esophageal cancer?

    <p>HER2-positive status is associated with more aggressive tumor invasion and lymph node spread. (C)</p> Signup and view all the answers

    Which of the following genetic conditions are associated with an increased risk of esophageal adenocarcinoma?

    <p>None of the above (D)</p> Signup and view all the answers

    Which of the following is TRUE about Barrett's esophagus?

    <p>It refers to the replacement of naturally occurring squamous cells within the lower esophagus with columnar or glandular epithelium. (A)</p> Signup and view all the answers

    What is the prevalence of Barrett's esophagus in the US population?

    <p>~5% (C)</p> Signup and view all the answers

    What is the risk of progression to cancer for a patient with high-grade dysplasia?

    <p>7% per year (C)</p> Signup and view all the answers

    In what population is familial clustering of Barrett’s esophagus most common?

    <p>Whites (D)</p> Signup and view all the answers

    Which of the following is NOT a risk factor for Barrett's esophagus?

    <p>Female sex (A)</p> Signup and view all the answers

    Which of the following diagnostic modalities is nearly 100% sensitive in diagnosing Barrett's esophagus?

    <p>Magnifying endoscopy (D)</p> Signup and view all the answers

    A patient with dysphagia is being worked up by the GI physician. The basic blood work shows iron-deficiency anemia. The upper endoscopy demonstrated a 'web-like' appearance of the lower esophagus. The Colonoscopy was unremarkable. Based on these findings, the patient is considered at high risk for...?

    <p>Esophageal squamous cell carcinoma (C)</p> Signup and view all the answers

    What is the recommended frequency of endoscopic surveillance for Barrett’s Esophagus with no dysplasia?

    <p>Every 3-5 years (D)</p> Signup and view all the answers

    Study Notes

    Esophageal Cancer

    • Anatomy: Esophagus extends from the Upper Esophageal Sphincter (UES) to the Esophagogastric Junction (GEJ).
    • Average resting lumen size: 2cm (AP) x 3cm (laterally).
    • UES is approximately 15cm from incisors, and GEJ is approximately 40cm from incisors.
    • Esophagus divided into cervical, thoracic (upper, middle, lower), and abdominal sections.
    • No serosa.
    • Blood supply from segmental end-arteries.
    • Lymphatic system abundant in submucosal plane.
    • Regional nodal basins: cervical, thoracic, and abdominal.
    • Cervical nodes include recurrent laryngeal, jugular, and supraclavicular.
    • Thoracic nodes include thoracic duct and subcarinal.
    • Abdominal nodes include celiac, left gastric, splenic, common hepatic, lesser curve, retroperitoneal, and diaphragmatic.

    Epidemiology of Esophageal Cancer

    • Males are affected more than females (3:1 ratio).
    • Typically diagnosed between 60-70 years.
    • 6th leading cause of cancer death globally.
    • Incidence varies geographically with highest rates in Central Asia and Northern China.
    • Adenocarcinoma more common in USA, increasing in prevalence.
    • Squamous cell carcinoma (SCC) most prevalent globally.
    • Overall 5-year survival rate approximately 18%.

    Definition of Esophageal Cancer

    • Esophageal Cancer: Tumor epicenter within the esophagus, lower extent >2cm from EGJ.
    • GE Junction Cancer: Tumor lower extent within 2cm of GEJ, involving any portion of esophagus.
    • Gastric Cancer: Tumor epicenter >2cm below GEJ.
    • Siewert Classification: Categorizes esophagogastric cancers based on tumor location (I, II, and III) regarding treatment approach.

    Risk Factors

    • Adenocarcinoma:*

    • Barrett's esophagus: Significant risk factor (30-60x).

    • Gastroesophageal Reflux Disease (GERD): Increased risk with increased symptom duration.

    • Smoking: Double the risk.

    • Obesity: Triple the risk.

    • Male sex: Triple the risk.

    • Radiation therapy history: 5x higher risk.

    • Genetic mutations (e.g., TP53, ARID1A, SMAD4): Associated with esophageal adenocarcinoma.

    • Squamous Cell Carcinoma (SCC):*

    • Smoking: Quadruple the risk.

    • Alcohol: Pentaple the risk.

    • Smoking and Alcohol: Synergistic effect, significantly increasing risk (44x).

    • Male sex: Double the risk.

    • Age: Risk increases with age.

    • Plummer-Vinson syndrome: Associated with risk.

    • Achalasia, Zenker's Diverticula: Elevated risk due to stasis and inflammation.

    • Tylosis, HPV 16: Increased risk.

    • Genetic mutations (e.g., TP53, CCND1, MDM2): Associated with SCC.

    Biomarker Screening

    • HER2: Protein linked to potential aggressive cancer behavior with variations in prevalence across cancer types. Screening with IHC/ISH is recommended for diagnosis.
      • Poorer prognosis, more aggressive tumor invasion, lymph node spread are associated with HER2 positivity.
    • MSI/MMR: Mutation detection is particularly considered for recurrent, locally advanced, or metastatic cases. It's helpful for determining the role of PD-1 inhibitors in treatment.
    • PD-L1: Useful in advanced stages, evaluated with IHC, to determine the potential use of PD-1 inhibitors.

    Genetic Syndromes

    • Tylosis (Howell-Evans syndrome): Rare, autosomal dominant condition with elevated risk of esophageal SCC, requiring screening from 20 years.
    • Familial Barrett's Esophagus: Clustering of cases within families, predisposes to esophageal adenocarcinoma. Screening starting at 40 years recommended for high risk groups.
    • Bloom's Syndrome and Fanconi Anemia: Rare, inherited conditions increasing risk for various cancers, including esophageal SCC, warranting regular endoscopic screening.

    Barrett's Esophagus

    • Epidemiology: 5% of US population, 1% globally.
    • Risk Factors: Age, obesity, GERD duration, male sex, white race, tobacco, familial history, and hiatal hernias.
    • Pathology: Substitution of squamous epithelium with intestinal-type epithelium.
    • Natural History: Progression to dysplasia and cancer. Risk of progression depends on grade.
    • Presentation: Reflux symptoms, sometimes asymptomatic.
    • Diagnosis: Endoscopy, biopsies, potentially WATS3D, other advanced endoscopy options for diagnosis.
    • Management: PPI, NSAIDs, aspirin, endoscopic removal/ablation for dysplasia, surveillance.
    • Surveillance: Different frequency/biopsy approaches according to Barrett's dysplasia grade.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the anatomy, blood supply, and epidemiology of esophageal cancer. Learn about the sections of the esophagus, the regional lymphatic system, and demographic data related to cancer incidence and mortality. Test your knowledge on this critical health topic.

    More Like This

    Esophageal Cancer
    5 questions

    Esophageal Cancer

    ReceptiveAntigorite avatar
    ReceptiveAntigorite
    Esophageal Cancer Clinical Features Quiz
    18 questions
    Esophageal Cancer Staging Quiz
    5 questions
    Use Quizgecko on...
    Browser
    Browser